Gary Chiang

VP, Translational Science at eFFECTOR Therapeutics

No bio yet


Org chart

No direct reports

Teams


Offices

This person is not in any offices


eFFECTOR Therapeutics

eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).


Industries

Employees

11-50

Links